The states where recreational cannabis will be on the ballot are California, Arizona, Nevada, Maine and Massachusetts, while North Dakota, Arkansas, Montana and Florida are considering medical marijuana legalization. California in particular is an interest to investors. According to Arcview Group, a company that links investors with cannabis companies, has shown the market for both recreational and medicinal marijuana is expected to reach a value of $22 billion by 2020 from the $7 billion it is today, if California says yes.
California already has the most comprehensive medical marijuana law in the country, which includes edibles, and therefore it is not surprising some of the most creative cannabis infused edibles were originated in the western state. Finore Mining Inc. (OTC: FNREF) just announced late yesterday an agreement for the acquisition of KushTown USA LLC, a leading California Marijuana Beverage Company. Kushtown USA for example is specializing in medicated water, soda, hot sauce and barbecue sauce products infused with cannabis. The company offers 20 different varieties of medicated sodas on its website. The sodas and drinks come in varieties of carbonated and non-carbonated beverages, with flavors like Cherry Cola, lemonade, fruit punch, and lemon lime, all infused with a medical marijuana THC oil tincture. For more information about the California based company, please visit and check out http://www.kushtownusa.com
The creator of Kushtown USA, Peter Moret, has an interesting story behind the company. In early 1999, Moret's mother became ill from breast cancer. In addition to the chemotherapy treatments, Moret research additional possible treatments for dealing with the aches and pains from the cancer. After researching cannabis's medical effects, he created a Medical Marijuana tincture, called it Kushtown tincture, and gave his mother a single serving of the tincture in tea, which she then started drinking regularly. The cannabis infused teas not only helped in dealing with the aches and pains from cancer, but also increased her appetite and activity. The company's goal today is to create and innovate delicious, effective, and cutting edge products that establish the company as a leader amongst edible companies.
Cannabics Pharmaceuticals Inc. (OTC: CNBX) recently announced the start of a clinical study in Israel for cancer patients utilizing Cannabics' SR Capsules. This is one of the world's first clinical studies specifically examining the effect of cannabis utilizing a medically standardized edible delivery system. The company describes itself as a licensed R&D based in Israel dedicated to the development of palliative and personalized Anti-Cancer treatments harnessing the versatile therapeutic values of cannabinoids to create tailored therapies for cancer patients. Their integrated technology has created a successful medically standardized delivery system offering patients natural, reliable and safe therapy.
Terra Tech Corp (OTCQX: TRTC) is a cannabis-focused agriculture company which operates through two segments: Hydroponic Produce and Cannabis Products. Terra Tech integrates the natural world with technology to create sustainable solutions for medical cannabis production, extraction and distribution, plant science research and development, food production and Closed Environment Agriculture. The company has recently announced that its subsidiary, Edible Garden, a retail seller of fresh hydroponic produce, herbs, and floral products, has started shipping its line of 4-inch potted living herbs to private American reginal supermarket chain, Wegmans Food Markets Inc.
Medical Marijuana Inc. (OTC: MJNA) through its subsidiaries and investment holdings, offers a portfolio of products, services, technology and businesses for the medical marijuana and industrial hemp markets. The company has announced that its portfolio company AXIM Biotechnologies, Inc. has secured private funding to continue its pharmaceutical clinical trials program in cannabinoid research and development for multiple indications. This is a perfect example of how varied the use for medical cannabis may be, AXIM's future plans for future cannabinoid-based clinical development include: Parkinson's disease, Alzheimer's disease/dementia, ADHD, PTSD, autism, restless leg syndrome, glaucoma and more.
United Cannabis Corp. (OTCQB: CNAB) has announced that its joint venture with Jamaica-based Cannabis Research & Development, will commence a trial program in partnership with the Rastafari Studies Centre for Cannabis Research, University of West Indies, Mona, to create protocols for the growth of Ital Standards that in turn be used as a monitor for the processing, cultivation and consumption of marijuana. The Joint Venture's original task will be to take note and confirm the genetics of the Centre's preliminary plantings, and to provide an outlook in the development of suitable standards and training approaches for the future.
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
For "The Latest Buzz in Financial News", SIGN UP & Visit: http://www.FinancialBuzz.com
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
For further information:
Media Contact: email@example.com , +1-877-601-1879